The evidence described above suggested that the HMGCR inhibitor enhanced the FXR overexpression-mediated decreases in migration, adhesion, invasion and angiogenesis via the inhibition of cholesterol synthesis in human bladder cancer cells. Here, NR1H4 is linked to urinary bladder cancer.